Skip to content

A randomized controlled trial of internet-based cognitive behavioral therapy for breast cancer patients with climacteric symptoms.

A randomized controlled trial of internet-based cognitive behavioral therapy for breast cancer patients with climacteric symptoms. - Internet-based CBT for climacteric symptoms after breast cancer.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON42362
Enrollment
248
Registered
2015-08-04
Start date
2015-08-01
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overgangsklachten Climacteric symptoms menopausal symptoms

Interventions

The CBT and relaxation training will consist of 6 weekly sessions that also include *homework* assignments (e.g., keeping a daily diary to monitor symptoms and their precipitants). It comprises the
(3) relaxation and stress reduction
(4) cognitive restructuring of unhelpful thoughts and (5) encouraging helpful behavioral strategies (e.g., pacing activities. The primary focus of the CBT is on hot flushes and night sweats, but oth

Sponsors

Antoni van Leeuwenhoek Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: The study sample will be composed of 248 women, younger than 50 years of age at time of breast cancer diagnoses or PBSO, with histologically confirmed primary breast cancer (stages: T1 - T4, N0 - N3 and M0). All women will have been premenopausal at the time of diagnosis, and will have experienced a treatment-induced menopause due to (neo)adjuvant chemotherapy, hormonal therapy or or oophorectomy. Women may currently be receiving adjuvant hormonal therapy. In case of treatment-induced menopause due to adjuvant chemotherapy (with the exception of herceptin), treatment should have been completed a minimum of 4 months and a maximum of 5 years prior to study entry. For women who receive neo-adjuvant chemo, we will use 4 month post-surgery or post-radiation therapy as the minimal time since treatment. Oophorectomy should have been completed no more than 5 years prior to study entry. All women should be disease-free at time of study entry. Potential eligible women will be screened for the presence of menopausal symptoms. Potentially eligible women will be screened for the presence of problematic hot flushes or night sweats during the past 2 months. Moreover, in the last week they should have experienced at least 10 hot flushes or night sweats during the past week and these hot flushes/night sweats should have been experienced as problematic (as indicated by an average score of two or higher on three items of the HFRS).

Exclusion criteria

Exclusion criteria: Women will be excluded from the study if they lack basic proficiency in Dutch, if they have serious cognitive or psychiatric problems that would preclude them from following the intervention or completing the study questionnaires, or if they have no internet access. Patients participating in concurrent studies or rehabilitation programs to alleviate their menopausal problems will also be excluded.

Design outcomes

Primary

MeasureTime frame
The primary outcomes are menopausal complaints, as assessed with a menopausal complaints questionnaire called FACT-ES, and hot flushes and night sweats as assessed by the Hot Flushes Rating Scale (HFRS).

Secondary

MeasureTime frame
The secondary study outcomes are sexuality problems (SAQ); sleep quality (GSQS); psychological distress (HADS) and health related quality of life (MOS SF- 36).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)